This inventor holds 1 USPTO granted patent. Top assignee: Abbvie Inc.. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Sara Martinelli and Her Patent on Chronic Pain Treatment.
Introduction
Sara Martinelli is an inventor associated with Rome, Italy. Her patent work concerns a potential approach to treating chronic pain by inhibiting the interaction between nerve growth factor (NGF) and the TrkA receptor.
Latest Patents
Martinelli is credited with 1 patent. The patent, “Molecules that are able to inhibit the binding between NGF and the TrkA receptor as analgesics with prolonged effect,” describes using an anti-NGF antibody to inhibit NGF binding to TrkA and block TrkA’s biological activity. The stated purpose is to prepare a medicine for treating or preventing chronic pain.
Career Highlights
The available information associates Martinelli with AbbVie Inc. and identifies her patent contribution in the field of pain treatment. The patent focuses on a biological mechanism that may support analgesic effects over an extended period.
Collaborations
Martinelli’s listed coworkers include Flaminia Pavone and Antonino Cattaneo. Their names are associated with the same research and patent context.
Conclusion
Sara Martinelli’s patent work centers on inhibiting NGF–TrkA signaling as a potential strategy for chronic pain treatment and prevention.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile